01-03-2021 | Dabigatran | Case report
Edoxaban/rivaroxaban
Drug hypersensitivity reactions and drug cross-reactivity: 3 case reports
Published in: Reactions Weekly | Issue 1/2021
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event